Posts Tagged ‘funding opportunities’

Funding available from Genentech

Genentech, a biotech company with offices in Hillsboro, Oregon, is looking to fund research projects, health-related programs and events, and fellowships related to the following therapeutic areas: Genentech funds general research, translational research, other research or development projects, and other initiatives of research organizations, labs, and academic institutions. Genentech also supports programs and events such as: patient services, patient outreach, patient education, disease education, fundraisers, health screenings, scientific/medical meetings, conferences, seminars and symposia. Applications are … Read More

Information meeting – NSF and DoD fellowships for first-year grad students

Attention first-year graduate students: Research Funding & Development Services is holding a short information meeting on Tuesday, August 28, at 1 p.m. in Mackenzie Hall 2136 to talk to any interested students about applying for fellowships from the National Science Foundation and the Department of Defense. These opportunities are limited to students in their first year of graduate school. This workshop will feature students who have received graduate student funding awards as well as information … Read More

Limited submission grants with upcoming deadlines

Sponsors of the following awards have restricted the number of proposals they will accept from a single an institution. If you’re interested in applying for one of these opportunities, please be sure to fill out the limited submission form by the internal deadline listed below. To learn more about the limited submissions process at OHSU, visit the Limited Submissions web page. To apply for a grant that’s listed as “review at the department level required,” … Read More

NIH Director’s Pioneer and New Innovator awards due in October

The 2013 NIH Director’s Pioneer Award Program (DP1) provides up to $500,000 per year for up to five years in support of individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on a broad area of biomedical or behavioral research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already … Read More

Updated: Important information about PCORI applications from OHSU

Updated 6/4: Because many of these applications will require institutional support–especially from the clinical enterprise–we are asking that interested applicants send their letters of intent for review. Institutional review will insure that: Optimal institutional collaborations and commitments are in place, particularly those that involve the OHSU clinical enterprise and its regional partners; Applications won’t be duplicative or conflict with one another; and Collaborations and synergies that could strengthen proposals are identified. Please send draft versions … Read More

Summer deadlines for American Heart research grants and fellowships

The American Heart Association has announced its summer deadlines for a wide range of funding opportunities relating to cardiovascular disease and stroke. All proposals and applications will be due either July 17th or 18th, 2012. Don’t forget that earlier this year, the Association enacted new policies regarding membership and application fees. Find the full program descriptions below.

National Academies Science & Technology fellowships, due April 27

The Christine Mirzayan Science & Technology Policy Graduate Fellowship Program offers scientists a chance to delve into the analytical process that informs U.S. science and technology policy.  Graduate and professional school students and early career post-graduates (U.S. and non-U.S. citizens) are eligible to apply for these awards sponsored by the National Academies. The program is a hands-on training and educational fellowship consisting of a twelve-week session that takes place in Washington, D.C. Letters of reference for the Fall … Read More

DoD releases 2012 breast and ovarian cancer research funding announcements

The Department of Defense (DoD) has released RFAs for its highly anticipated Breast and Ovarian Cancer Research Programs. Deadlines vary—find the full program announcements below for more information.

More pilot funding from OCTRI, letters of intent due March 26

The Oregon Clinical and Translational Research Institute (OCTRI) has announced it will be accepting letters of intent for an additional pilot funding opportunity. The Catalyst Pilot Award for Translational Research seeks collaborative, multidisciplinary projects that will lead to further research and funding in translational research. It supports collection of preliminary data or infrastructure work necessary to lead to a large grant application or significant licensing agreement. Funding is for up to $100,000 per awardee. Award focus … Read More

Funding from OCTRI and ONPRC, letters of intent due March 16 & 19

The Oregon Clinical and Translational Research Institute (OCTRI) and the Oregon National Primate Research Center (ONPRC) have issued the following requests for proposals for pilot funding: ONPRC/OCTRI Collaborative Research Program Description: Provides pilot funding to encourage the use non-human primates (NHP) or NHP-derived materials for new collaborative projects that will lead to new external funding of research with clear translational outcomes. Priority will be given to new collaborations between established investigators at ONPRC and basic … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.